Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Ullmann, A. Adams, C.J. Bossley, T. Oates, C.M. Lloyd, A. Bush, S. Saglani (London, United Kingdom). IL-33 and airway remodelling in paediatric severe therapy resistant asthma. Eur Respir J 2012; 40: Suppl. 56, 4709

Member's Comments

No comment yet.

Related content which might interest you: Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Severe therapy resistant asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=312 Year: 2003 Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD> Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Role of neutrophils in airway inflammation in children with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006 Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Implication of interleukin-18 in airway remodelling in refractory asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Implication of interleukin-18 in airway remodelling in refractory asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 Outcome of COPD exacerbations treated with and without oral steroids in relation to airway and systemic inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005 Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 IL-33 in patients with severe uncontrolled allergic asthma Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives Source: Eur Respir Rev 2015; 24: 594-601 Year: 2015 Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Anti-IL-5 therapy and the airway microbiome in asthma. Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 Problematic severe asthma Source: Eur Respir Mon 2012; 56: 22-39 Year: 2012 Parameters associated with persistent airflow obstruction in chronic severe asthma Source: Eur Respir J 2004; 24: 122-128 Year: 2004 Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009